Glycosylated boron dipyrromethene fluorophore derivatives as well as preparation and application thereof
A technology of fluorobodipyrrole and its derivatives, which is applied in the field of glycosylated fluorobodipyrrole anti-tumor photosensitive drugs and its preparation, and can solve skin phototoxicity, weak tissue penetration ability, and uncertain composition of photosensitizers And other problems, to achieve the effect of not easy skin phototoxicity, strong tissue penetration ability, and low cost
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Examples
Embodiment 1
[0040] 1) the compound (100 mg, 0.09 mmol), (R is Ac, n is 1) (110 mg, 0.26 mmol), CuSO 4 ·5H 2 O (15 mg, 0.06 mmol) and sodium ascorbate (24 mg, 0.12 mmol) were dissolved in 7 ml CHCl 3 , ethanol and water (volume ratio 12:1:1), vigorously stirred at room temperature for 24 hours. CH 2 Cl 2 and water extraction, the organic layer with Na 2 SO 4 After drying, spin dry under reduced pressure. in CH 2 Cl 2 / methanol (20:1 v / v) is the eluent, purified by silica gel column chromatography to obtain the compound: (R is Ac, n is 1) (71 mg, 53%). H NMR spectrum[ 1 H NMR (400 MHz, CDCl 3 )]: δ = 8.13 (d, J = 16.8 Hz, 2 H, CH=CH), 7.78 (s, 1 H, triazole-H), 7.60 (d, J = 8.8 Hz, 4 H, ArH), 7.58 (d, J = 17.6 Hz, 2 H, CH=CH), 7.20 (d, J = 8.8 Hz, 2 H, ArH), 7.15 (d, J = 8.8 Hz, 2 H, ArH), 6.96 (d, J = 8.8 Hz, 4 H, ArH), 5.25 (s, 2 H, OCH 2 ), 5.23-5.16 (m, 1 H, H4), 5.12-5.06 (m, 1 H, H3), 5.03 (dd, J 1 = 9.6Hz, J 2 = 8.0 Hz, 1 H, H2), 4.67 (dt,1 H, J ...
Embodiment 2
[0042] compound (200 mg, 0.18 mmol), (R is H, n is 1) (100 mg, 0.40 mmol), CuSO 4 ·5H 2 O (15 mg, 0.06 mmol) and sodium ascorbate (24 mg, 0.12 mmol) were dissolved in 7 ml CHCl 3 ﹑In a mixture of ethanol and water (volume ratio 12:1:1), stir vigorously at room temperature for 24 h. The reaction mixture was CH 2 Cl 2 and water extraction. Na for organic layer 2 SO 4 After drying, spin dry under reduced pressure. in CH 2 Cl 2 / methanol (10:1, v / v) is eluent, and silica gel column chromatography obtains product: (R is H, n is 1) (126 mg, 51%). H NMR spectrum[ 1 H NMR (400 MHz, DMSO-d 6 )]: δ = 8.37 (s, 1 H, triazole-H), 8.07 (d, J = 16.4 Hz, 2 H, CH=CH), 7.58 (d, J = 8.8 Hz, 4 H, ArH), 7.44 (d, J = 16.8 Hz, 2 H, CH=CH), 7.37 (d, J = 8.0 Hz, 2 H, ArH), 7.27 (d, J = 8.8 Hz, 2 H, ArH), 7.07 (d, J = 8.4 Hz, 4 H, ArH), 5.22 (s, 2 H, OCH 2 ), 5.13 (d, J = 4.8 Hz, 1 H, OH), 4.98 (d, J = 4.4 Hz, 1 H, OH), 4.94 (d, J = 4.8 Hz, 1 H, OH), 4.63 (t, ...
Embodiment 3
[0044] compound (100 mg, 0.09 mmol), (R is Ac, n is 2) (110 mg, 0.24 mmol), CuSO 4 ·5H 2 O (15 mg, 0.06 mmol) and sodium ascorbate (24 mg, 0.12 mmol) were dissolved in 7 ml CHCl 3 , ethanol and water (volume ratio 12:1:1), vigorously stirred at room temperature for 24 hours. CH 2 Cl 2 and water extraction, the organic layer was washed with Na 2 SO 4 After drying, spin dry under reduced pressure. in CH 2 Cl 2 / methanol (20:1 v / v) is the eluent, purified by silica gel column chromatography to obtain the compound (R is Ac, n is 2) (74 mg, 53%). H NMR spectrum[ 1 H NMR (400 MHz, CDCl 3 )]: δ = 8.12 (d, J = 16.4 Hz, 2 H, CH=CH), 7.89 (s, 1 H, triazole-H), 7.60 (d, J = 8.4 Hz, 4 H, ArH), 7.57 (d, J = 16.8 Hz, 2 H, CH=CH), 7.20 (d, J = 8.8 Hz, 2 H, ArH), 7.16 (d, J = 8.8 Hz, 2 H, ArH), 6.97 (d, J = 8.4 Hz, 4 H, ArH), 5.26 (s, 2 H, OCH 2 ), 5.20 (t, J= 9.6 Hz, 1 H, H4), 5.08 (t, J = 9.2 Hz, 1 H, H3), 4.99 (dd, J 1 = 9.2 Hz, J 2 = 8.0 Hz, 1 H,...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com